Our CEO, Dr. Heidi Wang, was invited to speak at Biologics World Taiwan 2026.
She shared insights on global regulatory strategy and drug development from IND to NDA.
🔗 Read more: lnkd.in/gEJci5TH
#OBIPharma #RegulatoryStrategy #DrugDevelopment #ADC #BWT2026 #BiologicsWorldTaiwan #IMAPAC

UK–EU SPS Negotiations Could Realign GB with EU Biocides & Pesticides Regulations.

Learn more... www.bluefrogscientific.com/c...

#SPS #PlantProtectionProducts #PPP #Pesticides, #Biocides #BiocidalProducts #BPR #RegulatoryStrategy #BiocideRegulation #PesticideRegulation

Natural and Sustainability Position for Food Ingredients Company - CSG Developing a natural and sustainability positioning for a food ingredients company, aligning new technology with regulatory, industry, and consumer expectations.

Introducing breakthrough food‑tech innovation while staying true to what consumers see as natural. 🌱✨

confidentstrategygroup.com/work/natural...

#FoodTech #Sustainability #Innovation #NaturalIngredients #FutureOfFood #RegulatoryStrategy #BrandPositionin #ConfidentStrategyGroup #WeAreConfident

Photo of Jennifer Burke, Lumanity Clinical & Regulatory expert authors an article on FDA animal testing.

Are you prepared for how the FDA plans to drastically reduce animal testing and how it may impact your pipeline? Check out Lumanity's perspective in a recent pharmaphorum article: buff.ly/axmMlIv

#DrugDevelopment #RegulatoryStrategy #NAMs #Oncology #FDA #PharmaInnovation

Interactions with the U.S. #FDA represent some of the most pivotal moments in the product development lifecycle. Access key strategies to ensure your organization makes the most of every #FDA interaction: buff.ly/9zkotWO

#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs

Services | Synterex | Synterex In rare disease development, regulatory decision-making often hinges on limited, non-traditional data. Common challenges that arise in the rare disease space include small sample sizes, single-arm or ...

In rare diseases, the “n of 1” matters, and efficacy narratives help tell that story with clarity and impact. For more on #EfficacyNarratives in #RareDiseases, read our latest LinkedIn post: www.linkedin.com/feed/update/...

#ClinicalDevelopment #RegulatoryStrategy #OrphanDrugs

Text: View. De-Risking IND Submissions to Accelerate FDA Clearance. Lumanity logo.

#ICYMI: Check out our latest article, “De-Risking IND Submissions to Accelerate FDA Clearance" to explore the five most common reasons INDs are put on hold, and how the right preparation helps mitigate the risk: buff.ly/VzTW1za

#IND #FDA #Regulatory #RegulatoryStrategy #ClinReg

Export permits signed,
While others wait for license
Preparation meets opportunity.

#CBDPope #Haiku #ExportPermits #PreparationMeetsOpportunity #RegulatoryStrategy
#EUGMP #CannabisExport #InternationalTrade #CannabisIndustry #BusinessStrategy

Target SOL, XRP, and ADA as next-wave ETF candidates capitalizing on regulatory shifts and institutional demand. #AltcoinETFs #CRyptoIdeas #InvestmentIdeas #RedRobotIdeas #RegulatoryStrategy
redrobot.online/2025/05/cryp...

Target SOL, XRP, and ADA as next-wave ETF candidates capitalizing on regulatory shifts and institutional demand. #AltcoinETFs #CRyptoIdeas #InvestmentIdeas #RedRobotIdeas #RegulatoryStrategy
redrobot.online/2025/05/cryp...

Big Challenges Remain for Nanomaterials Under REACH.

REACH compliance for nanomaterials isn't straightforward, but is achievable...

www.bluefrogscientific.com/c...

#Nanomaterials #Nanoforms #REACHCompliance #ChemicalRegulation #NanoRegulation #RegulatoryScience #RegulatoryStrategy

Danone, Nestlé Risk Margin Erosion After CMA Baby Formula Report | Aitor Ortiz 🚨 𝗡𝗼 𝗳𝗶𝗻𝗲𝘀. 𝗡𝗼 𝗱𝗮𝘄𝗻 𝗿𝗮𝗶𝗱𝘀. 𝗡𝗼 𝗳𝗼𝗿𝗺𝗮𝗹 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻. 𝗬𝗲𝘁, 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲. Danone and Nestlé, who dominate the…

www.linkedin.com/posts/aitor-...

#competitionlaw #regulatorystrategy #CMA #marketstudy #brandpower #antitrust #investors #FMCG #retailrisk

Join Compliance Architects at MDMES in Austin from February 16-18. Our team will be at Booth 12, ready to discuss the latest in quality compliance. We look forward to meeting you! #MDMES25 #QualityCompliance #MedicalDevices #RegulatoryStrategy #ComplianceArchitects